{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:28:58Z","timestamp":1794068938671,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hacettepe University Scientific Research Unit","award":["014D12101003-818"],"award-info":[{"award-number":["014D12101003-818"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.clinbiochem.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T01:54:39Z","timestamp":1525226079000},"page":"15-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer"],"prefix":"10.1016","volume":"58","author":[{"given":"Elif Tugce","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Koksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funda","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.Gunnur","family":"Dikmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Icen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Maden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgen","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Akbiyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Emri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2018.05.001_bb0005","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0010","series-title":"Cancer Facts & Figures 2017","author":"American Cancer Society","year":"2017"},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.05.001_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/thoraxjnl-2014-206677","article-title":"Diagnostic procedures for non-small cell lung cancer: recommendations of the European Expert Group","volume":"71","author":"Dietel","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0020","article-title":"The combination of the tumor markers suggests the histological diagnosis of lung cancer","volume":"2017","author":"Liu","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.clinbiochem.2018.05.001_bb0025","first-page":"189","article-title":"Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study","volume":"32","author":"Ebert","year":"1994","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.05.001_bb0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1378\/chest.109.4.995","article-title":"CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer","volume":"109","author":"Lai","year":"1996","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.05.001_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/172460089400900206","article-title":"CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels","volume":"9","author":"Molina","year":"1994","journal-title":"Int. J. Biol. Markers"},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.05.001_bb0040","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1274::AID-CNCR7>3.0.CO;2-I","article-title":"Assessment of serum CYFRA 21-1 in lung cancer","volume":"77","author":"Muraki","year":"1996","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clinbiochem.2018.05.001_bb0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1097-0142(19930801)72:3<707::AID-CNCR2820720313>3.0.CO;2-X","article-title":"CYFRA 21-1. A new marker in lung cancer","volume":"72","author":"Stieber","year":"1993","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.05.001_bb0050","first-page":"11295","article-title":"Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2018.05.001_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3346\/jkms.2011.26.5.625","article-title":"Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer","volume":"26","author":"Kim","year":"2011","journal-title":"Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.05.001_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1378\/chest.108.1.163","article-title":"Cyfra 21-1 as a biologic marker of non-small cell lung cancer: evaluation of sensitivity, specificity, and prognostic role","volume":"108","author":"Wieskopf","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0065","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/IGC.0000000000000192","article-title":"Accuracy of serum human epididymis protein 4 in ovarian cancer diagnosis: a systematic review and meta-analysis","volume":"24","author":"Macedo","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0070","first-page":"893","article-title":"Investigation on the application significance of serum tumor biomarker HE4 detection in the diagnosis of lung cancer","volume":"29","author":"Hu","year":"2014","journal-title":"Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0075","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-14-0447","article-title":"HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review","volume":"23","author":"Karlsen","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0004563213500657","article-title":"Is serum human epididymis protein 4 ready for prime time?","volume":"51","author":"Ferraro","year":"2014","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.05.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2018.05.001_bb0090","first-page":"457","article-title":"Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer","volume":"36","author":"Dikmen","year":"2015","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0095","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1515\/cclm-2014-0041","article-title":"Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer","volume":"52","author":"Nagy","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/352670","article-title":"The diagnostic accuracy of HE4 in lung cancer: a meta-analysis","volume":"2015","author":"Cheng","year":"2015","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.clinbiochem.2018.05.001_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4999\/uhod.15739","article-title":"Diagnostic efficiency of HE4 and CYFRA 21-1 in patients with lung cancer","volume":"25","author":"Dikmen","year":"2015","journal-title":"Int. J. Hemat. Oncol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2018.05.001_bb0110","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.5588\/ijtld.13.0058","article-title":"Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis","volume":"17","author":"Liu","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2018.05.001_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000224628","article-title":"Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology","volume":"30","author":"Molina","year":"2009","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.05.001_bb0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s12032-013-0823-1","article-title":"The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer","volume":"31","author":"Petrovi\u0107","year":"2014","journal-title":"Med. Oncol."},{"issue":"3A","key":"10.1016\/j.clinbiochem.2018.05.001_bb0125","first-page":"1773","article-title":"Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer","volume":"25","author":"Molina","year":"2005","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.clinbiochem.2018.05.001_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clinbiochem.2004.05.007","article-title":"ProGRP: a new biomarker for small cell lung cancer","volume":"37","author":"Molina","year":"2004","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.clinbiochem.2018.05.001_bb0135","first-page":"4827","article-title":"The diagnostic and prognostic value of ProGRP in lung cancer","volume":"29","author":"Nisman","year":"2009","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.clinbiochem.2018.05.001_bb0140","first-page":"391","article-title":"Meta-analysis of serum gastrin-releasing peptide precursor as a biomarker for diagnosis of small cell lung cancer","volume":"18","author":"Lv","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.clinbiochem.2018.05.001_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000186247","article-title":"Tumor markers in chronic renal failure and hemodialysis patients","volume":"57","author":"Cases","year":"1991","journal-title":"Nephron"},{"issue":"9","key":"10.1016\/j.clinbiochem.2018.05.001_bb0150","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.21037\/jtd.2016.08.72","article-title":"Progastrin-releasing peptide as a diagnostic and therapeutic biomarker of small cell lung cancer","volume":"8","author":"Oh","year":"2016","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2018.05.001_bb0155","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7326\/0003-4819-105-5-698","article-title":"Elevated serum chromogranin A concentrations in small-cell lung carcinoma","volume":"105","author":"Sobol","year":"1986","journal-title":"Ann. Intern. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912018302431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912018302431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:51:46Z","timestamp":1757865106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912018302431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":31,"alternative-id":["S0009912018302431"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.05.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}